National Asset Management, Inc. Pacira Bio Sciences, Inc. Transaction History

National Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$28.4 - $50.7 $158,386 - $282,753	-5,577 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$36.31 - $46.83 $202,500 - $261,170	5,577 New	5,577 $253,000
Q3 2019 Nov 12, 2019	SELL	$35.66 - $44.99 $180,189 - $227,334	-5,053 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$36.57 - $47.97 $184,788 - $242,392	5,053 New	5,053 $220,000
Q1 2019 May 08, 2019	SELL	$36.47 - $42.17 $202,408 - $234,043	-5,550 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$41.31 - $52.16 $36,352 - $45,900	-880 Reduced 13.69%	5,550 $239,000
Q3 2018 Nov 08, 2018	SELL	$32.85 - $52.0 $3,843 - $6,084	-117 Reduced 1.79%	6,430 $317,000
Q2 2018 Oct 05, 2018	BUY	$27.5 - $39.8 $180,042 - $260,570	6,547 New	6,547 $210,000

257

48.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.12B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.